rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Thermo Fisher Scientific Inc

TMO · NYSE

Health CareLife-science toolsIn trendAI

TMO stood above a rising 150-day average in 22 of the last 52 weekly readings, including each of the last 6 weeks. It is 27.0% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
6 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$228.0M
Officials’ trades on record
180

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$118.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

180 disclosed lines: House 135, Senate 29, executive 16; 57 people.

WhoDidAmountTraded
Dan Newhouse House: U.S. House ClerkWA04soldspouse$1k–$15k10 Jul 2026filed 17 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k23 Jun 2026filed 22 Aug 2026
Markwayne Mullin Executive branch: Office of Government EthicsDepartment of Homeland Securitysold$15k–$50k10 Jun 2026filed 25 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k18 May 2026filed 1 Jul 2026
Dwight Evans House: U.S. House ClerkPA03sold$1k–$15k7 May 2026filed 15 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k28 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k27 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k17 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k18 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k17 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k12 Feb 2026filed 14 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months31
Buyers · sellers0 · 7
WhoDidSharesTraded
Gianluca PettitiPresident & COOsold400at $614.3831 Aug 2026filed 1 Sep 2026
Gianluca PettitiPresident & COOsold3,733at $614.3831 Aug 2026filed 1 Sep 2026
Marc N. CasperChairman & CEOsold101at $625.4124 Aug 2026filed 26 Aug 2026
Marc N. CasperChairman & CEOsold33at $626.5924 Aug 2026filed 26 Aug 2026
Marc N. CasperChairman & CEOsold79at $628.0124 Aug 2026filed 26 Aug 2026
Marc N. CasperChairman & CEOsold62at $628.7424 Aug 2026filed 26 Aug 2026
Marc N. CasperChairman & CEOsold2,727at $625.4621 Aug 2026filed 24 Aug 2026
Marc N. CasperChairman & CEOsold3,014at $626.5121 Aug 2026filed 24 Aug 2026
Marc N. CasperChairman & CEOsold1,791at $627.3921 Aug 2026filed 24 Aug 2026
Marc N. CasperChairman & CEOsold2,147at $628.6121 Aug 2026filed 24 Aug 2026
Marc N. CasperChairman & CEOsold321at $629.1021 Aug 2026filed 24 Aug 2026
Marc N. CasperChairman & CEOsold909at $625.4520 Aug 2026filed 24 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

News

Everyone who traded it

Dion J. Weisler Company insiderDirector · last 26 Sep 20260 · 0
Jennifer M. Johnson Company insiderDirector · last 26 Sep 20260 · 0
Karen S. Lynch Company insiderDirector · last 26 Sep 20260 · 0
R. Alexandra Keith Company insiderDirector · last 26 Sep 20260 · 0
Scott M. Sperling Company insiderDirector · last 26 Sep 20261 · 4
Gianluca Pettiti Company insiderPresident & COO · last 31 Aug 20260 · 15
James Meyer Company insiderSr. Vice President & CFO · last 28 Aug 20260 · 0
Joseph R. Holmes Company insiderVP & Chief Accounting Officer · last 28 Aug 20260 · 4
Lisa P. Britt Company insiderSr. VP and Chief HR Officer · last 28 Aug 20260 · 6
Marc N. Casper Company insiderChairman & CEO · last 28 Aug 20261 · 158
Michael D. Shafer Company insiderExecutive Vice President · last 28 Aug 20260 · 4
Thomas B. Shropshire Jr. Company insiderSVP and General Counsel · last 28 Aug 20260 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202517.4%
Free cash flow marginFY 2025 · to 31 Dec 202514.1%
Return on capital employedFY 2025 · to 31 Dec 20258.1%
Cash conversionFY 2025 · to 31 Dec 2025117%
Debt to equityFY 2025 · to 31 Dec 20250.80×
Research spendFY 2025 · to 31 Dec 20253.1%
Share count trendFY 2025 · to 31 Jan 2026-1.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$9.9B
Free cash flowFY 2025 · to 31 Dec 2025$6.3B

Analyst forecasts

No analyst forecasts yet.